Page last updated: 2024-11-04

sulforaphane and Prostatic Hyperplasia

sulforaphane has been researched along with Prostatic Hyperplasia in 2 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chambers, KF1
Bacon, JR1
Kemsley, EK1
Mills, RD1
Ball, RY1
Mithen, RF1
Traka, MH1
Myzak, MC1
Hardin, K1
Wang, R1
Dashwood, RH1
Ho, E1

Other Studies

2 other studies available for sulforaphane and Prostatic Hyperplasia

ArticleYear
Gene expression profile of primary prostate epithelial and stromal cells in response to sulforaphane or iberin exposure.
    The Prostate, 2009, Sep-15, Volume: 69, Issue:13

    Topics: Anticarcinogenic Agents; Cells, Cultured; Epithelial Cells; Gene Expression; Gene Expression Profili

2009
Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
    Carcinogenesis, 2006, Volume: 27, Issue:4

    Topics: Androgens; Anticarcinogenic Agents; Apoptosis; Cell Cycle; Epithelial Cells; Histone Deacetylase Inh

2006